De-novo collateral formation following acute myocardial infarction: Dependence on CCR2+ bone marrow cells

Journal of Molecular and Cellular Cardiology

Volumn 87, Issue , 2015, Pages 4-16

  Zhang, Hua ^a   Faber, James E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Collateral circulation; Coronary circulation; Genetic background; Hematopoietic cells; Myocardial infarction

Indexed keywords

CHEMOKINE RECEPTOR CCR2; FRACTALKINE; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN; CCR2 GENE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OCCLUSION; ENDOTHELIUM CELL; GENE; GENE INTERACTION; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE CONDUCTANCE; MALE; MCP1 GENE; MOUSE; MOUSE MODEL; NONHUMAN; OPTICAL RESOLUTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; VASCULARIZATION; ANIMAL; COLLATERAL CIRCULATION; DISEASE MODEL; GENETICS; HEART INFARCTION; HUMAN; ISCHEMIA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; QUANTITATIVE TRAIT LOCUS; SCAR;

MUS;

ANIMALS; BONE MARROW CELLS; CICATRIX; COLLATERAL CIRCULATION; DISEASE MODELS, ANIMAL; HUMANS; ISCHEMIA; MICE; MYOCARDIAL INFARCTION; QUANTITATIVE TRAIT LOCI; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 84938811415     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.07.020     Document Type: Article

References (85)

1. van Royen N., Piek J.J., Schaper W., Fulton W.F. A critical review of clinical arteriogenesis research. J. Am. Coll. Cardiol. 2009, 55:17-25.
2. Chilian W.M., Penn M.S., Pung Y.F., Dong F., Mayorga M., Ohanyan V., Logan S., Yin L. Coronary collateral growth-back to the future. J. Mol. Cell. Cardiol. 2012, 52:905-911.
3. Tomanek J.R. Coronary Vasculature: Development, Structure-Function, and Adaptations 2013, Springer US Inc. 10.1007/978-1-4614-4887-7.
4. Seiler C., Stoller M., Pitt B., Meier P. The human coronary collateral circulation: development and clinical importance. Eur. Heart J. 2013, 34:2674-2682.
5. Faber J.E., Dai X., Lucitti J. Genetic and environmental mechanisms controlling formation and maintenance of the native collateral circulation. Arteriogenesis - Molecular Regulation, Pathophysiology and Therapeutics I 2011, 1-22. Shaker Verlag, Aachen, GE, (Ch 1). E. Deindl, W. Schaper (Eds.).
6. Meisner J.K., Price R.J. Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications. Microcirculation 2010, 17:583-599.
7. Zhang H., Prabhakar P., Sealock R., Faber J.E. Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke. J. Cereb. Blood Flow Metab. 2010, 30:923-934.
8. Traupe T., Ortmann J., Stoller M., Baumgartner I., de Marchi S.F., Seiler C. Direct quantitative assessment of the peripheral artery collateral circulation in patients undergoing angiography. Circulation 2013, 128:737-744.
9. Shuaib A., Butcher K., Mohammad A.A., Saqqur M., Liebeskind D.S. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol. 2011, 10:909-921.
10. Al-Ali F., Elias J.J., Filipkowski D.E., Faber J.E. Acute ischemic stroke treatment, part 1: patient selection. "The 50% barrier and the capillary index score". Front. Neurol. 2015, 6:83.
11. Moore S.M., Zhang H., Maeda N., Doerschuk, Faber J.E. Cardiovascular risk factors cause premature rarefaction of the collateral circulation and greater ischemic tissue injury. Angiogenesis 2015, 18:265-281.
12. Chalothorn D., Clayton J.A., Zhang H., Pomp D., Faber J.E. Collateral density, remodeling and VEGF-A expression differ widely between mouse strains. Physiol. Genomics 2007, 30:179-191.
13. Chalothorn D., Faber J.E. Strain-dependent variation in native collateral function in mouse hindlimb. Physiol. Genomics 2010, 42:469-479.
14. Wang S., Zhang H., Wiltshire T., Sealock R., Faber J.E. Genetic dissection of the Canq1 locus governing variation in extent of the collateral circulation. PLoS ONE 2012, 7:e31910.
15. Sealock R., Zhang, Lucitti J.L., Moore S.M., Faber J.E. Congenic fine-mapping identifies a major causal locus for variation in the native collateral circulation and ischemic injury in brain and lower extremity. Circ. Res. 2014, 114:660-671.
16. Habib G.B., Heibig J., Forman S.A., Brown B.G., Roberts R., Terrin M.L., Bolli R. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991, 83:739-746.
17. Chalothorn D., Faber J.E. Formation and maturation or the murine native cerebral collateral circulation. J. Mol. Cell. Cardiol. 2010, 49:251-259.
18. Lucitti J.L., Mackey J., Morrison J., Haigh J., Adams R., Faber J.E. Formation of the collateral circulation is regulated by vascular endothelial growth factor-A and A disintegrin and metalloprotease family members 10 and 17. Circ. Res. 2012, 111:1539-1550.
19. Reiner L., Molnar J., Jimenez F.A., Freudenthal R.R. Interarterial coronary anastomoses in neonates. Arch. Pathol. 1961, 71:103-112.
20. van den Borne S.W., van de Schans V.A., Strzelecka A.E., Vervoort-Peters H.T., Lijnen P.M., Cleutjens J.P., Smits J.F., Daemen M.J., Janssen B.J., Blankesteijn W.M. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc. Res. 2009, 84:273-282.
21. Maxwell M.P., Hearse D.J., Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc. Res. 1987, 21:737-746.
22. Schaper W., Piek J.J., Munoz-Chapuli Wolf C., Ito W. Collateral circulation of the heart. Angiogenesis and Cardiovascular Disease 1999, 163. Oxford Univ Press. J.A. Ware, M. Simons (Eds.).
23. Toyota E., Warltier D.C., Brock T., Ritman E., Kolz C., O'Malley P., Rocic P., Focardi M., Chilian W.M. Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation 2005, 112:2108-2113.
24. Zehendner C.M., Luhmann H.J., Yang J.W. A simple and novel method to monitor breathing and heart rate in awake and urethane-anesthetized newborn rodents. PLoS ONE 2013, 8:e62628.
25. Smolock E.M., Ilyushkina I.A., Ghazalpour A., Gerloff J., Murashev A.N., Lusis A.J., Korshunov V.A. Genetic locus on mouse chromosome 7 controls elevated heart rate. Physiol. Genomics 2012, 44:689-698.
26. Lerman I., Harrison B.C., Freeman K., Hewett T.E., Allen D.L., Robbins J., Leinwand L.A. Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J. Appl. Physiol. 2002, 92:2245-2255.
27. Barnabei M.S., Palpant N.J., Metzger J.M. Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains. Physiol. Genomics 2010, 42A:103-113.
28. Shah A.P., Siedlecka U., Gandhi A., Navaratnarajah M., Al-Saud S.A., Yacoub M.H., Terracciano C.M. Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc. Res. 2010, 87:683-693.
29. Christensen L.P., Zhang R.L., Zheng W., Campanelli J.J., Dedkov E.I., Weiss R.M., Tomanek R.J. Postmyocardial infarction remodeling and coronary reserve: effects of ivabradine and beta blockade therapy. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H322-H330.
30. Zhang R.L., Christensen L.P., Tomanek R.J. Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction. Anat. Rec. (Hoboken) 2010, 293:839-848.
31. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
32. Walenta K.L., Bettink S., Bohm M., Friedrich E.B. Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res. Cardiol. 2011, 106:299-305.
33. Belema-Bedada F., Uchida S., Martire A., Kostin S., Braun T. Efficient homing of multipotent adult mesenchymal stem cells depends on frount-mediated clustering of CCR2. Cell Stem Cell 2008, 2:566-575.
34. Tsou C.L., Peters W., Si Y., Slaymaker S., Aslanian A.M., Weisberg S.P., Mack M., Charo I.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 2007, 117:902-909.
35. Cheng G., Zhang H., Yang X., Tzima E., Ewalt K.L., Schimmel P., Faber J.E. Mini-tyrosyl-tRNA synthetase regulates ischemic angiogenesis, leukocyte recruitment, and vascular permeability. Am. J. Physiol. 2008, 295:R1138-R1146.
36. de Groot D., Grundmann S., Timmers L., Pasterkamp G., Hoefer I.E. Assessment of collateral artery function and growth in a pig model of stepwise coronary occlusion. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H408-H414.
37. van den Wijngaard J.P., Schulten H., van Horssen P., Ter Wee R.D., Siebes M., Post M.J., Spaan J.A. Porcine coronary collateral formation in the absence of a pressure gradient remote of the ischemic border zone. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1930-H1937.
38. Eckstein R.W. Development of interarterial coronary anastomoses by chronic anemia; disappearance following correction of anemia. Circ. Res. 1955, 3:306-310.
39. Scheel K.W., Williams S.E. Hypertrophy and coronary and collateral vascularity in dogs with severe chronic anemia. Am. J. Physiol. 1985, 249:H1031-H1037.
40. Vineberg A., Munro D.D., Cohen H., Buller W. Four years' clinical experience with internal mammary artery implantation in the treatment of human coronary artery insufficiency including additional experimental studies. J. Thorac. Surg. 1955, 29:1-32.
41. Gonzalez N.R., Liebeskind D.S., Dusick J.R., Mayor F., Saver J. Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives. Neurosurg. Rev. 2013, 36:175-184.
42. Mac Gabhann F., Peirce S.M. Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle. Microcirculation 2010, 17:333-347.
43. Dedkov E.I., Zheng W., Tomanek R.J. Compensatory growth of coronary arterioles in postinfarcted heart: regional differences in DNA synthesis and growth factor/receptor expression patterns. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1686-H1693.
44. Bexell D., Setser R.M., Schoenhagen P., Lieber M.L., Brener S.J., Ivanc T.B., Balazs E.M., O' Donnell T.P., Stillman A.E., Arheden H., Wagner G.S., White R.D. Influence of coronary artery stenosis severity and coronary collateralization on extent of chronic myocardial scar: insights from quantitative coronary angiography and delayed-enhancement MRI. Open Cardiovasc. Med. J. 2008, 2:79-86.
45. Deindl E., Zaruba M.M., Brunner S., Huber B., Mehl U., Assmann G., Hoefer I.E., Mueller-Hoecker J., Franz W.M. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006, 20:956-958.
46. Park H.J., Chang K., Park C.S., Jang S.W., Ihm S.H., Kim P.J., Baek S.H., Seung K.B., Choi K.B. Coronary collaterals: the role of MCP-1 during the early phase of acute myocardial infarction. Int. J. Cardiol. 2008, 130:409-413.
47. Sahinarslan A., Kocaman S.A., Topal S., Ercin U., Bukan N., Yalcin R., Timurkaynak T. Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. Coron. Artery Dis. 2010, 21:455-459.
48. Arslan U., Kocaoglu I., Falay M.Y., Balc M., Duyuler S., Korkmaz A. The association between different monocyte subsets and coronary collateral development. Coron. Artery Dis. 2012, 23:16-21.
49. Morimoto H., Takahashi M., Izawa A., Ise H., Hongo M., Kolattukudy P.E., Ikeda U. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ. Res. 2006, 99:891-899.
50. Tongers J., Roncalli J.G., Losordo D.W. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc. Res. 2010, 79:200-206.
51. Tillmanns J., Rota M., Hosoda T., Misao Y., Esposito G., Gonzalez A., Vitale S., Parolin C., Yasuzawa-Amano S., Muraski J., De Angelis A., Lecapitaine N., Siggins R.W., Loredo M., Bearzi C., Bolli R., Urbanek K., Leri A., Kajstura J., Anversa P. Formation of large coronary arteries by cardiac progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1668-1673.
52. Bearzi C., Leri A., Lo Monaco F., Rota M., Gonzalez A., Hosoda T., Pepe M., Qanud K., Ojaimi C., Bardelli S., D'Amario D., D'Alessandro D.A., Michler R.E., Dimmeler S., Zeiher A.M., Urbanek K., Hintze T.H., Kajstura J., Anversa P. Identification of a coronary vascular progenitor cell in the human heart. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15885-15890.
53. Jujo K., Hamada H., Iwakura A., Thorne T., Sekiguchi H., Clarke T., Ito A., Misener S., Tanaka T., Klyachko E., Kobayashi K., Tongers J., Roncalli J., Tsurumi Y., Hagiwara N., Losordo D.W. Cxcr4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11008-11013.
54. Beohar N., Rapp J., Pandya S., Losordo D.W. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J. Am. Coll. Cardiol. 2010, 56:1287-1297.
55. Rubanyi G.M. Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors. Mol. Ther. 2013, 21:725-738.
56. Zhang S., Ge J., Zhao L., Qian J., Huang Z., Shen L., Sun A., Wang K., Zou Y. Host vascular niche contributes to myocardial repair induced by intracoronary transplantation of bone marrow CD34+ progenitor cells in infarcted swine heart. Stem Cells 2007, 25:1195-1203.
57. Vandervelde S., van Luyn M.J., Rozenbaum M.H., Petersen A.H., Tio R.A., Harmsen M.C. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc. Res. 2007, 73:783-793.
58. Boyle A.J., Yeghiazarians Y., Shih H., Hwang J., Ye J., Sievers R., Zheng D., Palasubramaniam J., Palasubramaniam D., Karschimkus C., Whitbourn R., Jenkins A., Wilson A.M. Myocardial production and release of mcp-1 and sdf-1 following myocardial infarction: differences between mice and man. J. Transl. Med. 2011, 9:150.
59. Italiani P., Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 2014, 5:514.
60. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014, 6:13.
61. Kolattukudy P.E., Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ. Res. 2012, 110:174-189.
62. Tarzami S.T., Calderon T.M., Deguzman A., Lopez L., Kitsis R.N., Berman J.W. MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. Biochem. Biophys. Res. Commun. 2005, 335:1008-1016.
63. Weir R.A., Murphy C.A., Petrie C.J., Martin T.N., Clements S., Steedman T., Wagner G.S., McMurray J.J., Dargie H.J. Monocyte chemoattractant protein-1: a dichotomous role in cardiac remodeling following acute myocardial infarction in man?. Cytokine 2010, 50:158-162.
64. Schenk S., Mal N., Finan A., Zhang M., Kiedrowski M., Popovic Z., McCarthy P.M., Penn M.S. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007, 25:245-251.
65. Maddaluno M., Di Lauro M., Di Pascale A., Santamaria R., Guglielmotti A., Grassia G., Ialenti A. Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis 2011, 217:113-119.
66. Butoi E.D., Gan A.M., Manduteanu I., Stan D., Calin M., Pirvulescu M., Koenen R.R., Weber C., Simionescu M. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules. Biochim. Biophys. Acta 1813, 2011:2026-2035.
67. White G.E., Greaves D.R. Fractalkine: a survivor's guide: chemokines as anti-apoptotic mediators. Arterioscler. Thromb. Vasc. Biol. 2012, 32:589-594.
68. Zernecke A., Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc. Res. 2010, 86:192-201.
69. Xuan W., Liao Y., Chen B., Huang Q., Xu D., Liu Y., Bin J., Kitakaze M. Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc. Res. 2011, 92:385-393.
70. Liu H., Jiang D. Fractalkine/CX3CR1 and atherosclerosis. Clin. Chim. Acta 2011, 412:1180-1186.
71. Tang J., Wang J., Yang J., Kong X., Zheng F., Guo L., Zhang L., Huang Y. Mesenchymal stem cells over-expressing sdf-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur. J. Cardiothorac. Surg. 2009, 36:644-650.
72. Tang Y.L., Zhu W., Cheng M., Chen L., Zhang J., Sun T., Kishore R., Phillips M.I., Losordo D.W., Qin G. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ. Res. 2009, 104:1209-1216.
73. Takeda Y., Costa S., Delamarre E., Roncal C., Leite de Oliveira, Squadrito M.L., Finisguerra V., Deschoemaeker S., Bruyère F., Wenes M., Hamm A., Serneels J., Magat J., Bhattacharyya T., Anisimov A., Jordan B.F., Alitalo K., Maxwell P., Gallez B., Zhuang Z.W., Saito Y., Simons M., De Palma M., Mazzone M. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 2011, 479(7371):122-126.
74. Spring H., Schuler T., Arnold B., Hammerling G.J., Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18111-18116.
75. Yamamoto K., Takahashi T., Asahara T., Ohura N., Sokabe T., Kamiya A., Ando J. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J. Appl. Physiol. 2003, 95:2081-2088.
76. DiPersio J.F. Diabetic stem-cell "mobilopathy". N. Engl. J. Med. 2011, 365:2536-2538.
77. Sanganalmath S.K., Stein A.B., Guo Y., Tiwari S., Hunt G., Vincent R.J., Huang Y., Rezazadeh A., Ildstad S.T., Dawn B., Bolli R. The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. J. Mol. Cell. Cardiol. 2009, 47:528-535.
78. Yin L., Ohanyan V., Pung Y.F., Delucia A., Bailey E., Enrick M., Stevanov K., Kolz C.L., Guarini G., Chilian W.M. Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ. Res. 2012, 110:241-252.
79. Przyklenk K., Vivaldi M.T., Arnold J.M., Schoen F.J., Kloner R.A. Capillary anastomoses between the left anterior descending and circumflex circulations in the canine heart: possible importance during coronary artery occlusion. Microvasc. Res. 1986, 31:54-65.
80. le Noble F., Fleury V., Pries A., Corvol P., Eichmann A., Reneman R.S. Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc. Res. 2005, 65:619-628.
81. Avolio E., Meloni M., Spencer H.L., Riu F., Katare R., Mangialardi G., Oikawa A., Rodriguez-Arabaolaza I., Dang Z., Mitchell K., Reni C., Alvino V.V., Rowlinson J., Livi U., Cesselli D., Angelini G., Emanueli C., Beltrami A.P., Madeddu P. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ. Res. 2015, 116:e81-e94.
82. Tirziu D., Jaba I.M., Yu P., Larrivée B., Coon B.G., Cristofaro B., Zhuang Z.W., Lanahan A.A., Schwartz M.A., Eichmann A., Simons M. Endothelial nuclear factor-κB-dependent regulation of arteriogenesis and branching. Circulation 2012, 126:2589-2600.
83. Moraes F., Paye J., Mac Gabhann F., Zhuang Z.W., Zhang J., Lanahan A.A., Simons M. Endothelial cell-dependent regulation of arteriogenesis. Circ. Res. 2013, 113:1076-1086.
84. Stein O., Dabach Y., Ben-Naim M., Halperin G., Stein Y. Lower macrophage recruitment and atherosclerosis resistance in FVB mice. Atherosclerosis 2006, 189:336-341.
85. Dragneva G., Korpisalo P., Ylä-Herttuala S. Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success. Dis. Model. Mech. 2013, 6:312-322.